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Purpose/Objective: At the Danish wards for radiotherapy 
there are different rules regarding the intervals that have to 
pass from the moment the patients applies moisturizer until 
they can be treated. This is due to the fact that it is unclear 
whether the cream can cause bolus effect, thereby causing 
the dose to move towards the skin. This would increase the 
damages to the patient’s skin during the radiotherapy. There 
is no evidence on the use of moisturizers. Consequently, we 
are not aware whether a bolus effect occurs. For the patients 
the use of creams is very pleasant which is why it would be 
useful for them to know whether a certain number of hours 
have to pass between the application and the therapy. For 
the staff it would be good to know whether creams cause 
bolus effect when it is or has been on the skin within the past 
hours before the therapy. 
Materials and Methods: We have carried out an experimental 
trial testing whether creams cause bolus effect. We used two 
pieces of pork which we each divided into three squares in 
order to test our three preparations: Decubal Original Clinic 
Cream, Panthenol cream and Panthetonol ointment. All scans 
were carried out using a 64 slice Philips Brilliance Big Bore CT 
scanner. 
On one piece of pork we tested whether it is necessary to 
wait up to four hours before initiating the therapy if cream 
has been applied to the skin. We tested this by applying 5 ml. 
cream to each square and subsequently carrying out a scan 
each hour for four hours. On the other piece of pork we 
applied 1 ml. cream to each square whereupon we scanned 
the pork. Afterwards we applied another ml. and repeated 
the scan, until we reached 10 ml. When all scans were 
completed, we calculated the skin dose for each square using 
the planning software Pinnacle. We calculated the skin dose 
of both 6 MV and 18 MV. 
Results: In Table 1 we see that when we applied 1 ml cream 
to the pork the dose was increased between 1,35 % - 5,43 at 
6 MV and 2,78 % - 4,18 % at 18 MV depending on the cream 
we used. For the results of 2 ml the dose increase was 
between 4,12 % - 9,30 % at 6 MV and 4,50 % - 10,43 % at 18 
MV depending on what cream we used.  
 
 
1 Decubal 
6 MV  
2 P 
cream 6 
MV 
3 P 
ointm 6 
MV 
1 Decubal 
18 MV 
2 P 
cream 
18 MV  
3 P 
ointm 
18 MV 
1 
ml 
5,43 % 4,77 % 1,35 % 4,18 % 3,78 % 2,78 % 
2 
ml 
9,30 % 6, 35 % 4,12 % 8,23 % 10,43 % 4,50 % 
Table 1: The increase of dose in % 
 
For the time experiment we made figure 1 to show the 
results. Time0 is when the preparations were first applied. 
Time1 is the dose calculated after 1 hour. By 4 hours we can 
see that it is only Decubal cream (blue line) that gives a 
lower dose than at Time0 both at 6 MV and at 18 MV but it 
still gives a bolus effect. 
 
 
 
Conclusions: According to our results of the ml. 
measurements we can conclude: Panthenol ointment is the 
preparation which causes the smallest bolus effect. 
According to our results of the time measurements we can 
conclude: After four hours all the preparations in question 
still cause bolus effect. Because the bolus effect occurs even 
by very small quantities of cream and as it does not 
disappear within four hours, the patients should postpone the 
application until the therapy is over, whereby the additional 
bolus effect can be completely avoided.  
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Purpose/Objective: The mechanism of lung damage caused 
by ionizing radiation is not well known. In some studies, it is 
claimed that oxidative stress and cytokine activities might 
cause the damage. XRCC1, XRCC3 and HHR2L genes are 
required for repairing single or double strand chain breaks of 
DNA via different pathways. We would like to present results 
of our ongoing TUBAP 2012/190 study which has been started 
in November 2012. 
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Materials and Methods: Following the approval of Trakya 
University Local Ethics Committee (TUHDYEK-2012/11), this 
study has been performed in Experimental Research 
Laboratory, Biophysics Laboratory and Radiation Oncology 
Department in Trakya University. 30 female and 30 male rats 
(60 albino Wistar-Albino rats in total) were divided to 4 
groups and each group was contained with 15 rats. 
-Control Group-Male Rats (CG-MR): observed male rats, 
-Control Group-Female Rats (CG-FR): observed female rats, 
-Experimental Group-Male Rats (EG-MR): irradiated male rats, 
-Experimental Group-Female Rats (EG-FR): irradiated female 
rats. 
Whole-lung radiotherapy was performed in experimental 
groups by using Linear Accelerator. Source skin distance (SSD) 
was 100 cm. Half-value layers were measured and radiation 
doses were calculated for each rat. 10 Gray of radiation was 
given in a single fraction. At the end of 6 weeks of follow-up 
after radiotherapy, sacrification was performed and XRCC1, 
XRCC3, HHR2L gene expression levels were examined in lung 
tissue samples after DNA isolation. 
Results: Study results are shown in Table 1. XRCC1, XRCC3 
and HHR2L gene expression levels in female control group 
were higher as compared to male control group and p-values 
were statistically significant (respectively p <0.001, <0.001, 
<0.01). There was no statistically significant difference 
between female experimental group and female control 
group for gene expression levels. In male experimental 
group, the only statistically significant difference was for 
XRCC1 gene expression compared to male control group (p 
=0.033). Besides this, statistically significant difference was 
observed for XRCC1, XRCC3 and HHR2L genes expression 
levels between female radiotherapy group and male 
radiotherapy group. And this result was parallel with the 
difference between control groups (respectively; p <0.001, 
<0.001, =0.034). 
 
Table 1. XRCC1, XRCC3, HHR2L gene expression results 
 
Control 
Group  
Female 
Rats 
(CG-FR) 
Control 
Group  
Male Rats 
(CG-MR) 
Experimental 
Group 
Female Rats 
(EG-FR)  
Experimental  
Group  
Male Rats 
(EG-MR) 
XRCC1 
Mean 
Median 
Minimum-
Maximum  
 
26.57 
26.59 
21.43-32.30 
 
20.05 
19.81 
19.06-21.32 
 
27.00 
26.54 
21.52-30.21 
 
20.37 
20.08 
18.45-23.42 
XRCC3 
Mean 
Median 
Minimum-
Maximum 
 
24.92 
24.90 
22.33-27.98 
 
19.53 
19.91 
17.4-21.07 
 
24.94 
25.12 
21.45-27.12 
 
20.21 
20.12 
17.45-21.78 
HHR2L 
Mean 
Median 
Minimum-
Maximum 
 
24.30 
24.36 
22.51-26.12 
 
22.94 
23.56 
19.24-26.21 
 
24.31 
24.56 
21.23-25.98 
 
23.59 
23.85 
19.21-27.52 
 
Conclusions: In order to make these results meaningful, lung 
tissues of all rats will be examined histopathologically and 
lung toxicity caused by ionizing radiation will be scored. And 
then statistical comparison will be performed and results will 
be shared.  
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Purpose/Objective: Because of its high survival, in breast 
cancer patients it’s crucial to study the possibilities of 
developing a radiation-induced cancer. In its development 
are implicated low range radiation doses (up to20 to 30Gy, 
depending on the tumor type) received by the healthy tissue, 
except for second sarcoma, induced at higher doses. The 
dose over the entire breast is 50Gy, and therefore this dose is 
outside the above range.  
The purpose of this study was to analyze the effects of boost 
performed, whose value is between 10 and16 Gy [included 
within the dosage range previously mentioned as potential 
inducer of second cancers in areas as homolateral (HL) and 
contralateral lung (CL) and breast (CB)], and find out if there 
is any difference if its delivered by PH or E and, therefore, 
one technique is more cancer inductive than the other. In 
PREVENT 2013 we presented the preliminary results. Here we 
present the definitive results in 30 patients. 
Materials and Methods: 30 consecutive breast cancer 
patients, treated with conservative intend, undergoing 
radiotherapy, were enrolled. The Eclipse (Varian) version 
10.0 planning system was used for treatment planning and 
dose-volume histograms (DVH) analysis. Statistical analysis of 
data was performed by MATLAB software. 
For each patient, two different boost planning options were 
calculated; one by PH and another by E. DVH of each were 
analyzed and determined: a) Volume (cm3) of HL and CL 
receiving a dose between 5 and 20 Gy (V5-20 Gy). b) Volume 
(cm3) of CB receiving a dose between 5 and 10 Gy (V5-10 Gy). 
c) Volume (cm3) of esophagus receiving a dose between 10 
and 20 Gy (V10-20 Gy). These cancer induction dose ranges 
had been reported by Schneider et al in 2011.Also, the mean 
integral dose in the treated breast (MIDB) and the mean 
integral dose received in the whole simulation volume 
(MIDWSV) were determined for each patient. A Wilcoxon-
Mann Whitney test was performed for each organ. 
